ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2014

MiR-141 targets ZEB2 to suppress HCC progression.

Shi-Min Wu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.